Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-25T21:09:34.091Z Has data issue: false hasContentIssue false
  • English
  • Français

CNS drug discovery in the 21st century

From genomics to combinatorial chemistry and back

Published online by Cambridge University Press:  06 August 2018

Steven Paul
Steven Paul*
Affiliation:
CNS Discovery Research and Clinical Investigations, Eli Lilly and Company, Indianapolis, IN, USA
Get access Rights & Permissions [Opens in a new window]

Abstract

The discovery of new drugs for psychiatric and neurological disorders has been greatly facilitated by advances in molecular biology, genetics and chemistry. Several examples are given of how these revolutionary advances have been applied to the discovery of new drugs that selectively modify serotonergic neurotransmission, including compounds which may prove to be more effective antidepressants.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 174 , Issue S37: Focus on schizophrenia , February 1999 , pp. 23 - 25
Copyright
Copyright © The Royal College of Psychiatrists, 1999 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adham, N., Kao, H. T., Schecter, L. E., et al (1993) Cloning of another human serotonin receptor (5-HTIF): a fifth 5-HTI receptor subtype coupled to the inhibition of adenylate cyclase. Proceedings of the National Academy of Sciences of the United States of America, 90, 408–412.Google Scholar
Artigas, F., Romero, L., de Montigny, C., et al (1996) Acceleration of the effect of selected antidepressant drugs in major depression by 5-HTIA antagonists. Trends in Neurosciences, 19, 378–383.CrossRefGoogle Scholar
Azmitia, E. C. & Whitaker-Azmitia, P. M. (1991) Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. Journal of Clinical Psychopharmacology, 52, 4–16.Google ScholarPubMed
Blier, P., de Montigny, C. & Chaput, Y. (1990) A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. Journal of Clinical Psychiatry, 51, 14–20.Google Scholar
deBlier, P. & de Montigny, C. (1994) Current advances and trends in the treatment of depression. Trends in Pharmacological Sciences, 15, 220–226.Google Scholar
Crabbe, J. C., Phillips, T. J., Feller, D. J., et al (1996) Elevated alcohol consumption in null mutant mice lacking 5-HTIB serotonin receptors. Nature Genetics, 14, 98–101.Google Scholar
Fuller, R. W. & Wong, D. T. (1990) Serotonin uptake and serotonin uptake inhibition. Annals of the New York Academy of Sciences, 600, 68–78.CrossRefGoogle ScholarPubMed
Johnson, K. W., Schaus, J. M., Durkin, M. M., et al (1997) 5-HTIF receptor agonists inhibit neurogenic dural inflammation in guinea pigs. Neuroreport, 8, 2237–2240.Google Scholar
Liang, P. & Pardee, A. B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967–971.Google Scholar
McCann, U. D., Seiden, L. S., Rubin, L. J., et al (1997) Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. Journal of the American Medical Association, 278, 666–672.Google Scholar
Nibuya, M., Nestler, E. J. & Duman, R. S. (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. Journal of Neuroscience, 316, 2365–2372.Google Scholar
Nonogaki, K., Strack, A. M., Dallman, M. F., et al (1998) Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nature Medicine, 4, 1152–1156.CrossRefGoogle ScholarPubMed
Paul, S. M., Wu, X., Liang, Y., et al (1997) Molecular strategies to novel antidepressant discovery. In Antidepressants: New Pharmacological Strategies (ed. Skolnick, P.), pp. 235–250. Totowa, NJ: Humana Press.Google Scholar
Potter, W. Z. & Manji, H. K. (1994) Clinical onset of antidepressant action: implications for new drug development. In Critical Issues in the Treatment of Affective Disorders (eds S. Z. Langer, N. Brunello, G. Racagni, et al), pp. 118–126. Basel: Karger.Google Scholar
Sanders-Bush, E. & Canton, H. (1995) Serotonin receptors: signal transduction pathways. In Psychopharmacology: The Fourth Generation of Progress (eds F. E. Bloom & D. J. Kupfer), pp. 431–441. New York: Raven Press.Google Scholar
Sandou, F., Amara, D. A., Dierich, A., et al (1994) Enhanced aggressive behavior in mice lacking 5-HTIB receptor. Science, 265, 1875–1878.Google Scholar
Tecott, L. H., Sun, L. M., Akana, S. F., et al (1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature, 374, 542–546.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.